financetom
Business
financetom
/
Business
/
Cantaloupe Says Chairman, CEO Up Ownership in Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cantaloupe Says Chairman, CEO Up Ownership in Company
Oct 2, 2024 10:22 PM

11:31 AM EDT, 10/01/2024 (MT Newswires) -- Cantaloupe (CTLP) said Tuesday its Chairman Douglas Bergeron has purchased an additional 285,000 shares of the company, bringing his direct ownership across various investment vehicles to more than one million shares.

Additionally, Bergeron holds shares through his former role as co-Managing Partner of Hudson Executive Capital, Cantaloupe's largest shareholder, the company said.

Cantaloupe also said Chief Executive Ravi Venkatesan has increased his personal stake in the company.

Shares of Cantaloupe were up more than 6% in recent trading.

Price: 7.89, Change: +0.48, Percent Change: +6.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bell Canada, Best Buy, Launch Best Buy Express, Will Open 167 Stores
Bell Canada, Best Buy, Launch Best Buy Express, Will Open 167 Stores
Jun 26, 2024
11:15 AM EDT, 06/26/2024 (MT Newswires) -- BCE's (BCE.TO) Bell Canada unit and Best Buy Canada, said Wednesday they formed a strategic partnership to introduce 167 small-format consumer-technology retail stores across Canada. The stores will be branded Best Buy Express. The inaugural Best Buy Express store has opened in Guildford Town Centre, Surrey, B.C. Customers can shop Best Buy's full...
Cyclacel Receives Notice of European Patent Grant for  Plogosertib; Shares Rise
Cyclacel Receives Notice of European Patent Grant for Plogosertib; Shares Rise
Jun 26, 2024
11:17 AM EDT, 06/26/2024 (MT Newswires) -- Cyclacel Pharmaceuticals ( CYCC ) said Wednesday the European Patent Office has notified the company of its intention to grant a patent for plogosertib, which is being studied for cancer treatment. The patent covers claims to pharmaceutical compositions of the PLK1 inhibitor and supports a switch to a new oral formulation with improved...
What's Going On With Carnival Stock?
What's Going On With Carnival Stock?
Jun 26, 2024
Carnival Corporation ( CCL ) shares are trading higher Wednesday after the company posted better-than-expected second-quarter financial results Tuesday.  The Details: Carnival's stock notched its best trading day of 2024 Tuesday after the company beat analysts' expectations on both the top and bottom line. The company said it continues to experience strong bookings momentum driven by record booking volumes for...
Repare Therapeutics Says Lunresertib With Folfiri Shows 'Promising' Efficacy, Tolerability in Phase 1 Solid Tumor Study
Repare Therapeutics Says Lunresertib With Folfiri Shows 'Promising' Efficacy, Tolerability in Phase 1 Solid Tumor Study
Jun 26, 2024
11:15 AM EDT, 06/26/2024 (MT Newswires) -- Repare Therapeutics ( RPTX ) said Wednesday that initial data from a phase one study of lunresertib, or RP-6306, combined with Folfiri showed promising efficacy and tolerability in patients with advanced solid tumors. The data helped identify the preliminary recommended phase 2 dose of 60 milligrams lunresertib twice a day with standard Folfiri,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved